Muriel Gondry

Title: Muriel Gondry: Innovator in Diketopiperazine Derivatives

Introduction

Muriel Gondry is a notable inventor based in Limours-en-Hurepoix, France. She has made significant contributions to the field of biochemistry, particularly in the synthesis of diketopiperazine derivatives. With a total of 2 patents to her name, her work has implications in various applications within biotechnology.

Latest Patents

Gondry's latest patents focus on polynucleotides and polypeptides coded by these polynucleotides, which are involved in the synthesis of diketopiperazine derivatives. The inventions concern novel isolated natural or synthetic polynucleotides and polypeptides, vectors comprising these polynucleotides, and micro-organisms transformed with them. Additionally, her patents detail methods for synthesizing diketopiperazine derivatives, including cyclodipeptides and diketopiperazine derivatives that are 3- and 6-substituted by α,β-unsaturated amino acid side chains.

Career Highlights

Throughout her career, Muriel Gondry has worked with prestigious organizations such as the Commissariat à l'Énergie Atomique and the Centre National de la Recherche Scientifique. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to significant advancements in her field.

Collaborations

Muriel has collaborated with esteemed colleagues, including Roger Genet and Sylvie Lautru, who have also made their mark in the scientific community. Their joint efforts have furthered research and development in biochemistry and related areas.

Conclusion

Muriel Gondry's contributions to the field of diketopiperazine derivatives through her patents and collaborations highlight her role as an influential inventor. Her work continues to inspire advancements in biotechnology and related disciplines.